| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.09 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.083 | 0.09 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.095 | 0.1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |